Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus.

Signal Transduct Target Ther · 2023 · PMC10073293 · PMID 37015918

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

However, cellular apoptotic analysis of pancreatic tissues did not show highly significant difference between the mice treated with IHMT-MST1-39 alone and those treated with drug combination (Supplementary Fig.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.